Tanvex BioPharma, Inc.

Tanvex BioPharma, Inc.verified

6541.TW

Price:

$60.6

Market Cap:

$16.05B

Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar in Taiwan and the United States. The company focuses on delivering biosimilars which target neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. Its products pipeline includes TX01 and TX-05 which have completed Phase III clinical trials; TX-04 and TX-16 that are in Phase I clinical trial; and TX-52 and other products which are in pre-clinical trial. The company was formerly known as Ruenvex Biotech, Inc. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands.

Industry

Biotechnology

IPO Date

2015-08-13

Stock Exchange

TAI

Ticker

6541.TW

The Enterprise Value as of December 2025 (TTM) for Tanvex BioPharma, Inc. (6541.TW) is 16.20B

According to Tanvex BioPharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 16.20B. This represents a change of 30.62% compared to the average of 12.40B of the last 4 quarters.

Tanvex BioPharma, Inc. (6541.TW) Historical Enterprise Value (quarterly & annually)

How has 6541.TW Enterprise Value performed in the past?

The mean historical Enterprise Value of Tanvex BioPharma, Inc. over the last ten years is 15.56B. The current 16.20B Enterprise Value has changed 10.31% with respect to the historical average. Over the past ten years (40 quarters), 6541.TW's Enterprise Value was at its highest in in the June 2016 quarter at 29.52B. The Enterprise Value was at its lowest in in the March 2020 quarter at 6.04B.

Quarterly (TTM)
Annual

Average

15.56B

Median

11.92B

Minimum

8.90B

Maximum

31.90B

Tanvex BioPharma, Inc. (6541.TW) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Tanvex BioPharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 166.47%

Maximum Annual Enterprise Value = 31.90B

Minimum Annual Increase = -56.99%

Minimum Annual Enterprise Value = 8.90B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202411.39B16.94%
20239.74B-27.45%
202213.43B-27.21%
202118.45B94.49%
20209.48B6.52%
20198.90B-23.24%
201811.60B-5.26%
201712.24B-56.99%
201628.47B-10.76%
201531.90B166.47%

Tanvex BioPharma, Inc. (6541.TW) Average Enterprise Value

How has 6541.TW Enterprise Value performed in the past?

The current Enterprise Value of Tanvex BioPharma, Inc. (6541.TW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

11.52B

5-year avg

12.50B

10-year avg

15.56B

Tanvex BioPharma, Inc. (6541.TW) Enterprise Value vs. Peers

How is 6541.TW’s Enterprise Value compared to its peers?

Tanvex BioPharma, Inc.’s Enterprise Value is greater than Ever Supreme Bio Technology Co., Ltd (14.20B), greater than Foresee Pharmaceuticals Co., Ltd. (11.85B), greater than Medigen Vaccine Biologics Corporation (12.45B), greater than Excelsior Medical Co., Ltd. (13.54B), greater than AP Biosciences Inc (12.24B), greater than YungShin Global Holding Corporation (15.23B), greater than PharmaEngine, Inc. (8.99B), greater than Acepodia, Inc. (4.31B), less than EirGenix Inc. (17.73B), greater than ScinoPharm Taiwan, Ltd. (11.68B),

Build a custom stock screener for Tanvex BioPharma, Inc. (6541.TW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tanvex BioPharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tanvex BioPharma, Inc. (6541.TW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tanvex BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Tanvex BioPharma, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Tanvex BioPharma, Inc. (6541.TW)?

What is the 3-year average Enterprise Value for Tanvex BioPharma, Inc. (6541.TW)?

What is the 5-year average Enterprise Value for Tanvex BioPharma, Inc. (6541.TW)?

How does the current Enterprise Value for Tanvex BioPharma, Inc. (6541.TW) compare to its historical average?